Broto, J. M., Martinez-Trufero, J., Beveridge, R. D., Carrasco-Garcia, I., Moura, D. S., Sebio, A., González-Billalabeitia, E., Ramos, R., Gutiérrez, A., Jurado, J. C., Valverde, C., Ledesma, P., Hindi, N. (2025). ImmunoSarc2 (Cohort 7a): A Spanish Sarcoma Group (GEIS) phase Ib trial of epirubicin and ifosfamide plus nivolumab in first line of advanced undifferentiated pleomorphic sarcoma (UPS).. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2025.43.16_suppl.11514